JPMorgan slashes forecasts for Dow, Rohm & Haas

13 October 2008 13:15  [Source: ICIS news]

LONDON (ICIS news)--JPMorgan has lowered its earnings outlook for US chemical producers Dow Chemical and Rohm and Haas, the investment bank's analysts said on Monday.

 

Dow’s third-quarter earnings per share (EPS) forecast was reduced to $0.43 from $0.68 as the company was still experiencing significant outages from hurricanes Gustav and Ike, JPMorgan said.

 

The bank reduced its 2009 estimate for the US’s largest chemicals producer to $2.40 from $2.85, and also lowered Dow's investment rating to ‘neutral’ from ‘overweight’.

 

JPMorgan said ultimate financing costs for the acquisition of Rohm and Haas were likely to rise due to the tight credit environment, while new capacities in emerging markets would likely to drive down demand for Dow’s ethylene-based products.

 

“The unpopular R&H acquisition will probably grow more so as R&H’s growth engine, its electronics business, faces new headwinds,” said the bank.

 

“Acquisition synergies will probably be delayed given the contracting demand environment,” it added.

 

The bank reduced its 2008 EPS forecast for Rohm and Haas to $3.10 from $3.45 and its 2009 outlook to $3.05 from $4.00.

 

“The EPS revision reflects weak electronics demand in Asia, slowing demand in Europe, more conservative growth in the US and a stronger US dollar,” it said.

 

Dow’s proposed $18.8bn (€13.9bn) acquisition of specialty chemicals producer R&H was likely to close in early 2009, the bank said.

 

($1 = €0.74)

 

To discuss issues facing the chemical industry go to ICIS connect


By: Mark Watts
+44 20 8652 3214

< previous article(VIDEO - ICIS news Europe Lunchtime Bulletin 30 October 2009)


AddThis Social Bookmark Button

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly